Literature DB >> 28468552

Accelerated Age-Dependent Hippocampal Volume Loss in Parkinson Disease With Mild Cognitive Impairment.

Christine B Schneider1, Markus Donix2, Katharina Linse1, Annett Werner3, Mareike Fauser1,4, Lisa Klingelhoefer1, Matthias Löhle1,4, Rüdiger von Kummer3, Heinz Reichmann5, Alexander Storch1,4,6.   

Abstract

BACKGROUND: Patients with Parkinson disease are at high risk of developing dementia. During the course of the disease, a substantial number of patients will experience a cognitive decline, indicating the dynamics of the underlying neuropathology. Magnetic resonance imaging (MRI) has become increasingly useful for identifying structural characteristics in radiological brain anatomy existing prior to clinical symptoms. Whether these changes reflect pathology, whether they are aging related, or both often remains unclear. We hypothesized that aging-associated brain structural changes would be more pronounced in the hippocampal region among patients with Parkinson disease having mild cognitive deficits relative to cognitively unimpaired patients.
METHODS: Using MRI, we investigated 30 cognitively healthy patients with Parkinson disease and 33 patients with nondemented Parkinson disease having mild cognitive impairment. All participants underwent structural MRI scanning and extensive clinical and neuropsychological assessments.
RESULTS: Irrespective of the study participants' cognitive status, older age was associated with reduced cortical thickness in various neocortical regions. Having mild cognitive impairment was not associated with an increased rate of cortical thinning or volume loss in these regions, except in the hippocampus bilaterally.
CONCLUSION: Patients with Parkinson disease having mild cognitive impairment show an accelerated age-dependent hippocampal volume loss when compared with cognitively healthy patients with Parkinson disease. This may indicate pathological processes in a key region for memory functioning in patients with Parkinson disease at risk of developing dementia. Structural MRI of the hippocampal region could potentially contribute to identifying patients who should receive early treatment aimed at delaying the clinical onset of dementia.

Entities:  

Keywords:  Parkinson disease; aging; hippocampus; mild cognitive impairment

Mesh:

Year:  2017        PMID: 28468552     DOI: 10.1177/1533317517698794

Source DB:  PubMed          Journal:  Am J Alzheimers Dis Other Demen        ISSN: 1533-3175            Impact factor:   2.035


  8 in total

1.  Neuropsychiatric Symptoms and Risk Factors in Mild Cognitive Impairment: A Cohort Investigation of Elderly Patients.

Authors:  A-N Yang; X-L Wang; H-R Rui; H Luo; M Pang; X-M Dou
Journal:  J Nutr Health Aging       Date:  2020       Impact factor: 4.075

2.  Meynert nucleus-related cortical thinning in Parkinson's disease with mild cognitive impairment.

Authors:  Siming Rong; Yan Li; Bing Li; Kun Nie; Piao Zhang; Tongtong Cai; Mingjin Mei; Lijuan Wang; Yuhu Zhang
Journal:  Quant Imaging Med Surg       Date:  2021-04

3.  White matter alterations in Parkinson's disease with normal cognition precede grey matter atrophy.

Authors:  Ivan Rektor; Alena Svátková; Lubomir Vojtíšek; Iva Zikmundová; Jirí Vaníček; András Király; Nikoletta Szabó
Journal:  PLoS One       Date:  2018-01-05       Impact factor: 3.240

Review 4.  Can neuroimaging predict dementia in Parkinson's disease?

Authors:  Juliette H Lanskey; Peter McColgan; Anette E Schrag; Julio Acosta-Cabronero; Geraint Rees; Huw R Morris; Rimona S Weil
Journal:  Brain       Date:  2018-09-01       Impact factor: 13.501

5.  Neuroimaging in Parkinson's disease dementia: connecting the dots.

Authors:  Rimona S Weil; Joey K Hsu; Ryan R Darby; Louis Soussand; Michael D Fox
Journal:  Brain Commun       Date:  2019-07-08

6.  Neutral Sphingomyelinase Behaviour in Hippocampus Neuroinflammation of MPTP-Induced Mouse Model of Parkinson's Disease and in Embryonic Hippocampal Cells.

Authors:  Samuela Cataldi; Cataldo Arcuri; Stéphane Hunot; François-Pierre Légeron; Carmen Mecca; Mercedes Garcia-Gil; Andrea Lazzarini; Michela Codini; Tommaso Beccari; Anna Tasegian; Bernard Fioretti; Giovanna Traina; Francesco Saverio Ambesi-Impiombato; Francesco Curcio; Elisabetta Albi
Journal:  Mediators Inflamm       Date:  2017-11-16       Impact factor: 4.711

7.  Entorhinal Cortex Atrophy in Early, Drug-naive Parkinson's Disease with Mild Cognitive Impairment.

Authors:  Xiuqin Jia; Zhijiang Wang; Tao Yang; Ying Li; Shuai Gao; Guorong Wu; Tao Jiang; Peipeng Liang
Journal:  Aging Dis       Date:  2019-12-01       Impact factor: 6.745

Review 8.  Parkinson's Disease and the Metal-Microbiome-Gut-Brain Axis: A Systems Toxicology Approach.

Authors:  Lady Johanna Forero-Rodríguez; Jonathan Josephs-Spaulding; Stefano Flor; Andrés Pinzón; Christoph Kaleta
Journal:  Antioxidants (Basel)       Date:  2021-12-28
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.